beta
APRI
Apricus Biosciences Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Apricus Biosciences Inc is a pharmaceutical company. It focuses on the development of product candidates in the areas of urology and rheumatology. The company has two product candidates currently in development invluding Vitaros and RayVa.
Market Cap: 35.3 Million
Primary Exchange: NASDAQ Capital Market
Website: http://www.apricusbio.com
Shares Outstanding: 15.2 Million
Float: 2.69 Million
Dividend: 0.0 (0.0%)
Beta: 0.434411
Sector: Healthcare
Industry: Drug Manufacturers
Ethical Flags
Longest drawdown: 2466 trading days
From: 2013-05-21 To: 2019-01-23
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|---|---|---|---|---|---|
| 2016-10-24 | 10.0 | 1.0 | 10.0 |